Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh
- 5 June 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 210 (10), 1582-1589
- https://doi.org/10.1093/infdis/jiu316
Abstract
Background. Pneumonia is the leading cause of childhood mortality globally. Respiratory syncytial virus (RSV) is the most important viral cause of pneumonia. Maternal serum antibody protects infants from RSV disease. The objective of our study was to characterize RSV antibody levels in mother-infant pairs. Methods. Serial serum samples were collected from mother-infant pairs in Bangladesh from the third trimester of pregnancy to 72 weeks postpartum and tested using an RSV antibody microneutralization assay. Serologic infection was defined as a 4-fold increase in antibody titer. Maternal antibody half-life was calculated using infant antibody titers from birth to 20 weeks. Results. The ratio of infant cord blood to maternal serum RSV antibody titers in 149 mother-infant pairs was 1.01 (95% confidence interval [CI], .99–1.03). Maternal RSV antibody titers in the third trimester and at birth were strongly correlated (R = 0.68). Antibody half-life was 38 days (95% CI, 36–42 days). Higher cord blood RSV antibody titers were associated with a lower risk of serologic infection (P = .01) and maintenance of antibody titer above a potentially protective threshold (P < .001). Conclusions. Efficient transplacental transfer of RSV-specific antibody from mother to the fetus was documented in mother-infant pairs in Asia. Higher cord blood antibody titers were associated with protection from serologic infection.Keywords
This publication has 36 references indexed in Scilit:
- Kinetics of the Neutralizing Antibody Response to Respiratory Syncytial Virus Infections in a Birth CohortJournal of Medical Virology, 2013
- Reducing mortality from childhood pneumonia and diarrhoea: The leading priority is also the greatest opportunityJournal of Global Health, 2013
- Challenges to Evaluating Respiratory Syncytial Virus Mortality in Bangladesh, 2004–2008PLOS ONE, 2013
- Importance of Timing of Maternal Combined Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Immunization and Protection of Young InfantsClinical Infectious Diseases, 2012
- The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi KenyaPLOS ONE, 2009
- The Burden of Respiratory Syncytial Virus Infection in Young ChildrenNew England Journal of Medicine, 2009
- Effectiveness of Maternal Influenza Immunization in Mothers and InfantsNew England Journal of Medicine, 2008
- The Role of Neutralizing Antibodies in Protection of American Indian Infants Against Respiratory Syncytial Virus DiseaseThe Pediatric Infectious Disease Journal, 2008
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981
- Respiratory-Syncytial-Virus Infections, Reinfections and ImmunityNew England Journal of Medicine, 1979